a public good project by the
Synthesis
Company
of California

© 2026

David C. Johnson | doi.page

0 works0 citations0 h-index

David C. Johnson

Johnson & Johnson (United States)(US)Vanderbilt University Medical Center(US)

Publications by Year

Research Areas

Herpesvirus Infections and Treatments, Cytomegalovirus and herpesvirus research, Virus-based gene therapy research, Toxin Mechanisms and Immunotoxins, Toxoplasma gondii Research Studies

Most-Cited Works

→ Herpes simplex virus turns off the TAP to evade host immunity(1995)796 cited
→ A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes(1994)559 cited
→ A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells(1988)505 cited
→ Herpesviruses remodel host membranes for virus egress(2011)453 cited
→ Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells(1994)337 cited
→ Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI(1988)331 cited

→ Human Cytomegalovirus Entry into Epithelial and Endothelial Cells Depends on Genes UL128 to UL150 and Occurs by Endocytosis and Low-pH Fusion(2005)328 cited

→ A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH(1992)328 cited

→ A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H(1993)317 cited

→ Characterization of the Human Cytomegalovirus gH/gL/UL128-131 Complex That Mediates Entry into Epithelial and Endothelial Cells(2007)308 cited